The average one-year price target for Idorsia (OTCPK:IDRSF) has been revised to $4.14 / share. This is an increase of 178.01% from the prior estimate of $1.49 dated March 3, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $2.41 to a high of $7.52 / share. The average price target represents an increase of 75.42% from the latest reported closing price of $2.36 / share.
What is the Fund Sentiment?
There are 15 funds or institutions reporting positions in Idorsia. This is an decrease of 3 owner(s) or 16.67% in the last quarter. Average portfolio weight of all funds dedicated to IDRSF is 0.11%, an increase of 208.71%. Total shares owned by institutions decreased in the last three months by 45.84% to 3,154K shares.
What are Other Shareholders Doing?
FDGRX - Fidelity Growth Company Fund holds 1,676K shares representing 0.67% ownership of the company. In its prior filing, the firm reported owning 1,468K shares , representing an increase of 12.42%. The firm increased its portfolio allocation in IDRSF by 51.77% over the last quarter.
FGKFX - Fidelity Growth Company K6 Fund holds 506K shares representing 0.20% ownership of the company. In its prior filing, the firm reported owning 466K shares , representing an increase of 7.95%. The firm increased its portfolio allocation in IDRSF by 50.46% over the last quarter.
FCGSX - Fidelity Series Growth Company Fund holds 375K shares representing 0.15% ownership of the company. In its prior filing, the firm reported owning 311K shares , representing an increase of 17.09%. The firm increased its portfolio allocation in IDRSF by 45.16% over the last quarter.
FBIOX - Biotechnology Portfolio holds 289K shares representing 0.12% ownership of the company. No change in the last quarter.
VTMGX - Vanguard Developed Markets Index Fund Admiral Shares holds 125K shares representing 0.05% ownership of the company. In its prior filing, the firm reported owning 1,221K shares , representing a decrease of 875.78%. The firm decreased its portfolio allocation in IDRSF by 87.80% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
